Martlet Capital is an early-stage investor based in Cambridge, providing patient capital to deep technology and life science startups with high growth potential.
We seek to support entrepreneurs with value beyond capital. We have experience in helping companies scale from first-round through to exit. Take a look at how we work and our investment focus.
SML and PervasID Announce Strategic Partnership to Bring High-Accuracy, Hands-Free UHF RFID Product Visibility to the Retail Market
.@Paragraf_Gr has acquired Cardea Bio, a biosensor company, to extend #graphene #electronics industry leadership https://t.co/1UwZIKjest https://t.co/AZiv8huK0LView all Tweets >